NCT03250520View on ClinicalTrials.gov

Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-Ca

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

January 28, 2022

Study Completion Date

June 28, 2022

Conditions
Brain Tumor, Pediatric, Brainstem GliomaBrain Tumor, Pediatric, Recurrent
Interventions
DRUG

Platinum acetylacetonate (1% wt) supported by sol-gel technology functionalized titania

Sol-gel process Pt(acac)2- F-TiO2 nanostructured material with antitumoral activity used as an alternative in the treatment of cancer tumors. The biocatalysts were prepared by the sol-gel route using the complex Pt(acac)2.

Trial Locations (1)

Unknown

Hospital Infantil de Mexico Federico Gomez, DF

All Listed Sponsors
lead

Hospital Infantil de Mexico Federico Gomez

OTHER

NCT03250520 - Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-Ca | Biotech Hunter | Biotech Hunter